Published in Arch Phys Med Rehabil on May 01, 2008
Quality of life and costs of spasticity treatment in German stroke patients. Health Econ Rev (2016) 1.39
Immunogenicity of botulinum toxins. J Neural Transm (Vienna) (2012) 0.99
Therapeutic use of botulinum toxin in neurorehabilitation. J Toxicol (2011) 0.84
A randomized, placebo controlled pilot trial of botulinum toxin for paratonic rigidity in people with advanced cognitive impairment. PLoS One (2014) 0.81
Dramatic changes in muscle contractile and structural properties after 2 botulinum toxin injections. Muscle Nerve (2015) 0.80
Evaluation of the cost per patient per injection of botulinum toxin A in upper limb spasticity: comparison of two preparations in 19 countries. Med Devices (Auckl) (2012) 0.79
Efficacy of botulinum toxin type a for treating chronic low back pain. Anesth Pain Med (2011) 0.76
Feasibility of video clip analysis on effect of botulinum toxin-A injection for post-stroke upper limb spasticity. Toxins (Basel) (2013) 0.75
Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study. BMJ Open (2015) 0.75
Functional influence of botulinum neurotoxin type A treatment (Xeomin®) of multifocal upper and lower limb spasticity on chronic hemiparetic gait. Neurol Int (2012) 0.75
Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study. Neurology (2017) 0.75
Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med (2002) 5.34
A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data. Neuroimage (2008) 3.91
Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron (2004) 3.59
Assessment scales for disorders of consciousness: evidence-based recommendations for clinical practice and research. Arch Phys Med Rehabil (2010) 2.64
Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache (2005) 2.16
Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke. Arch Phys Med Rehabil (2004) 1.66
Recommendations for the use of common outcome measures in traumatic brain injury research. Arch Phys Med Rehabil (2010) 1.65
Global white matter analysis of diffusion tensor images is predictive of injury severity in traumatic brain injury. J Neurotrauma (2007) 1.49
Discriminating schizophrenia and bipolar disorder by fusing fMRI and DTI in a multimodal CCA+ joint ICA model. Neuroimage (2011) 1.41
Investigation of relationships between fMRI brain networks in the spectral domain using ICA and Granger causality reveals distinct differences between schizophrenia patients and healthy controls. Neuroimage (2009) 1.37
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. Parkinsonism Relat Disord (2010) 1.31
Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Headache (2011) 1.28
Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity. Arch Phys Med Rehabil (2002) 1.27
Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population. Hum Genet (2009) 1.25
Neuropsychologic and functional outcome after complicated mild traumatic brain injury. Arch Phys Med Rehabil (2008) 1.20
Examination of performance validity test failure in relation to number of tests administered. Clin Neuropsychol (2014) 1.19
Identification of a CRYAB mutation associated with autosomal dominant posterior polar cataract in a Chinese family. Invest Ophthalmol Vis Sci (2006) 1.19
A Hybrid Machine Learning Method for Fusing fMRI and Genetic Data: Combining both Improves Classification of Schizophrenia. Front Hum Neurosci (2010) 1.18
Multifaceted genomic risk for brain function in schizophrenia. Neuroimage (2012) 1.16
A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort. Neuroimage (2012) 1.15
Development of the participation assessment with recombined tools-objective for use after traumatic brain injury. Arch Phys Med Rehabil (2011) 1.10
Semiblind spatial ICA of fMRI using spatial constraints. Hum Brain Mapp (2010) 1.10
Identification of NPPA variants associated with atrial fibrillation in a Chinese GeneID population. Clin Chim Acta (2010) 1.09
Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia. J Urol (2009) 1.07
Aerosol synthesis of cargo-filled graphene nanosacks. Nano Lett (2012) 1.06
Rare copy number deletions predict individual variation in intelligence. PLoS One (2011) 1.04
Vulnerability analysis and passenger source prediction in urban rail transit networks. PLoS One (2013) 1.03
Components of cross-frequency modulation in health and disease. Front Syst Neurosci (2011) 1.03
A novel DSPP mutation is associated with type II dentinogenesis imperfecta in a Chinese family. BMC Med Genet (2007) 1.02
A cross-sectional survey of severe fever with thrombocytopenia syndrome virus infection of domestic animals in Laizhou City, Shandong Province, China. Jpn J Infect Dis (2014) 1.01
Disrupted correlation between low frequency power and connectivity strength of resting state brain networks in schizophrenia. Schizophr Res (2012) 1.01
The reliability and validity of the brief symptom inventory-18 in persons with traumatic brain injury. Arch Phys Med Rehabil (2008) 1.01
A pilot multivariate parallel ICA study to investigate differential linkage between neural networks and genetic profiles in schizophrenia. Neuroimage (2009) 1.00
American Academy of Clinical Neuropsychology Consensus Conference Statement on the neuropsychological assessment of effort, response bias, and malingering. Clin Neuropsychol (2009) 1.00
Efficacy, tolerability, and immunogenicity of onabotulinumtoxina in a randomized, double-blind, placebo-controlled trial for cervical dystonia. Clin Neuropharmacol (2012) 0.99
Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials. Clin Ther (2007) 0.98
Guided exploration of genomic risk for gray matter abnormalities in schizophrenia using parallel independent component analysis with reference. Neuroimage (2013) 0.98
Genetic associations of brain structural networks in schizophrenia: a preliminary study. Biol Psychiatry (2010) 0.97
Rehabilitation needs of an inpatient medical oncology unit. Arch Phys Med Rehabil (2003) 0.95
Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States. Curr Med Res Opin (2009) 0.94
Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity. PM R (2011) 0.93
Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings. J Oncol Pharm Pract (2013) 0.93
The predictive validity of a brief inpatient neuropsychologic battery for persons with traumatic brain injury. Arch Phys Med Rehabil (2008) 0.93
Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity. Arch Phys Med Rehabil (2006) 0.92
Impairment versus deficiency in neuropsychological assessment: Implications for ecological validity. J Int Neuropsychol Soc (2009) 0.91
The evolution of chronic migraine: classification and nomenclature. Headache (2009) 0.91
Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am J Phys Med Rehabil (2004) 0.91
Is learning and memory different in a virtual environment? Clin Neuropsychol (2007) 0.90
Confirmatory factor analysis of the WAIS-IV/WMS-IV. Assessment (2011) 0.90
ICA order selection based on consistency: application to genotype data. Conf Proc IEEE Eng Med Biol Soc (2012) 0.89
Rapid-onset dystonia-parkinsonism: a fourth family consistent with linkage to chromosome 19q13. Mov Disord (2004) 0.88
Comparison of the Traumatic Brain Injury (TBI) Model Systems national dataset to a population-based cohort of TBI hospitalizations. Arch Phys Med Rehabil (2007) 0.88
A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(®)) in cervical dystonia. J Neural Transm (Vienna) (2013) 0.88
Rapid-onset dystonia-parkinsonism associated with the I758S mutation of the ATP1A3 gene: a neuropathologic and neuroanatomical study of four siblings. Acta Neuropathol (2014) 0.88
Validation of a model for evaluating outcome after traumatic brain injury. Arch Phys Med Rehabil (2003) 0.88
Incremental validity of neuropsychological evaluations to computed tomography in predicting long-term outcomes after traumatic brain injury. Clin Neuropsychol (2013) 0.88
Cataract mutation P20S of alphaB-crystallin impairs chaperone activity of alphaA-crystallin and induces apoptosis of human lens epithelial cells. Biochim Biophys Acta (2008) 0.88
Effort indicators within the California Verbal Learning Test-II (CVLT-II). Clin Neuropsychol (2009) 0.88
Changes in ratings of caregiver burden following a community-based behavior management program for persons with traumatic brain injury. J Head Trauma Rehabil (2002) 0.87
Predictors of driving outcome after traumatic brain injury. Arch Phys Med Rehabil (2002) 0.86
New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism. Parkinsonism Relat Disord (2012) 0.86
Evaluation of cranberry supplement for reduction of urinary tract infections in individuals with neurogenic bladders secondary to spinal cord injury. A prospective, double-blinded, placebo-controlled, crossover study. J Spinal Cord Med (2004) 0.86
Novel ACTG1 mutation causing autosomal dominant non-syndromic hearing impairment in a Chinese family. J Genet Genomics (2008) 0.86
Motor vehicle crashes and violations among drivers with multiple sclerosis. Arch Phys Med Rehabil (2002) 0.85
Zolpidem and restoration of consciousness. Am J Phys Med Rehabil (2014) 0.85
The impact of copy number deletions on general cognitive ability and ventricle size in patients with schizophrenia and healthy control subjects. Biol Psychiatry (2012) 0.85
Parallel ICA identifies sub-components of resting state networks that covary with behavioral indices. Front Hum Neurosci (2012) 0.84
Cognitive impairment in rapid-onset dystonia-parkinsonism. Mov Disord (2014) 0.84
A pipeline for copy number variation detection based on principal component analysis. Conf Proc IEEE Eng Med Biol Soc (2011) 0.84
A novel de novo frameshift mutation of RPGR ORF15 is associated with X-linked retinitis pigmentosa in a Chinese family. Mol Vis (2007) 0.84
Changes in neuropsychological performance after traumatic brain injury from inpatient rehabilitation to 1-year follow-up in predicting 2-year functional outcomes. Clin Neuropsychol (2010) 0.83
Rare copy number deletions predict individual variation in human brain metabolite concentrations in individuals with alcohol use disorders. Biol Psychiatry (2011) 0.83
Primary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin's lymphoma: cost-effectiveness analyses. J Med Econ (2013) 0.83
Neuropsychological impairment following traumatic brain injury: a dose-response analysis. Clin Neuropsychol (2003) 0.83
Novel mutations in ATP1A3 associated with catastrophic early life epilepsy, episodic prolonged apnea, and postnatal microcephaly. Epilepsia (2015) 0.82
Novel USH2A compound heterozygous mutations cause RP/USH2 in a Chinese family. Mol Vis (2010) 0.82
Assessing effort: differentiating performance and symptom validity. Clin Neuropsychol (2013) 0.81
A Genome-Wide Association Study Suggests Novel Loci Associated with a Schizophrenia-Related Brain-Based Phenotype. PLoS One (2013) 0.81
The distribution of repetitive DNAs along chromosomes in plants revealed by self-genomic in situ hybridization. J Genet Genomics (2007) 0.81
Examining the usability of a virtual reality driving simulator. Assist Technol (2007) 0.80
Antioxidant deactivation on graphenic nanocarbon surfaces. Small (2011) 0.80
Exploring difference and overlap between schizophrenia, schizoaffective and bipolar disorders using resting-state brain functional networks. Conf Proc IEEE Eng Med Biol Soc (2014) 0.80
Susceptibility-based functional brain mapping by 3D deconvolution of an MR-phase activation map. J Neurosci Methods (2013) 0.80
The impact of genome-wide supported schizophrenia risk variants in the neurogranin gene on brain structure and function. PLoS One (2013) 0.80
Examining the relationship between cognition and driving performance in multiple sclerosis. Arch Phys Med Rehabil (2010) 0.79
Trends in neutropenia-related inpatient events. J Oncol Pract (2012) 0.79
Comparisons of five performance validity indices in bona fide and simulated traumatic brain injury. Clin Neuropsychol (2014) 0.79
Post-concussion symptom reporting after multiple mild traumatic brain injuries. J Neurotrauma (2013) 0.79
Association of genetic copy number variations at 11 q14.2 with brain regional volume differences in an alcohol use disorder population. Alcohol (2012) 0.79
Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy. Support Care Cancer (2014) 0.79
Comorbid disease in persons with traumatic brain injury: descriptive findings using the modified cumulative illness rating scale. Arch Phys Med Rehabil (2012) 0.78
Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia. Schizophr Res (2004) 0.78
Three-way FMRI-DTI-methylation data fusion based on mCCA+jICA and its application to schizophrenia. Conf Proc IEEE Eng Med Biol Soc (2012) 0.78
Patient registry of outcomes in spasticity care. Am J Phys Med Rehabil (2012) 0.78
The "Miserable Minority" following mild traumatic brain injury: who are they and do meta-analyses hide them? Clin Neuropsychol (2012) 0.78
Sensitivity to brain dysfunction of the Halstead-Reitan vs an ability-focused neuropsychological battery. Clin Neuropsychol (2008) 0.78
A validity index for the MMPI-2. Arch Clin Neuropsychol (2002) 0.78
A novel SCN1A missense mutation causes generalized epilepsy with febrile seizures plus in a Chinese family. Neurosci Lett (2011) 0.77